These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36480256)

  • 1. Impact of Expanding Access to Continuous Glucose Monitoring Systems Among Insulin Users with Type 1 or Type 2 Diabetes.
    Pathak S; Kearin K; Kahkoska AR; Fuller KA; Staats B; Albright J; Stürmer T; Buse JB; Urick BY
    Diabetes Technol Ther; 2023 Mar; 25(3):169-177. PubMed ID: 36480256
    [No Abstract]   [Full Text] [Related]  

  • 2. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES.
    Mangrola D; Cox C; Furman AS; Krishnan S; Karakas SE
    Endocr Pract; 2018 Jan; 24(1):47-52. PubMed ID: 29144814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world outcomes of continuous glucose monitoring in adults with diabetes mellitus attending an Irish tertiary hospital.
    Courtney A; Smith D; Forde H
    Ir J Med Sci; 2023 Dec; 192(6):2763-2768. PubMed ID: 36940009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An estimate of the need for continuous glucose monitoring in type 2 diabetes with intensive insulin treatment in secondary healthcare.
    Trolle C; Christensen M; Hansen KW
    Diabet Med; 2024 May; 41(5):e15298. PubMed ID: 38308405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus.
    Ehrhardt NM; Chellappa M; Walker MS; Fonda SJ; Vigersky RA
    J Diabetes Sci Technol; 2011 May; 5(3):668-75. PubMed ID: 21722581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology Settings.
    Mayberry LS; Guy C; Hendrickson CD; McCoy AB; Elasy T
    J Gen Intern Med; 2023 Aug; 38(11):2546-2552. PubMed ID: 37254011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of Continuous Glucose Monitoring Is Linked to Improved Glycemic Control and Fewer Clinical Events in Type 1 and Type 2 Diabetes in the Veterans Health Administration.
    Reaven PD; Newell M; Rivas S; Zhou X; Norman GJ; Zhou JJ
    Diabetes Care; 2023 Apr; 46(4):854-863. PubMed ID: 36807492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology.
    Galindo RJ; Aleppo G
    Diabetes Res Clin Pract; 2020 Dec; 170():108502. PubMed ID: 33065179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods.
    JDRF CGM Study Group
    Diabetes Technol Ther; 2008 Aug; 10(4):310-21. PubMed ID: 18828243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.